Company Description

Grid Therapeutics is an emerging clinical stage biotechnology company based on fundamental principles of anti-tumor immunity. Grid Therapeutics has a unique strategy to rapidly and efficiently develop novel tumor-specific therapeutic antibodies for the treatment of multiple cancer types directly from single human B cells.